Related Experiment Video
Updated: Oct 16, 2025

Isolation and Functional Characterization of Human Ventricular Cardiomyocytes from Fresh Surgical Samples
Published on: April 21, 2014
Cardiomyocyte Dysfunction in Inherited Cardiomyopathies
Roua Hassoun1,2, Heidi Budde1,2, Andreas Mügge1,2
1Institut für Forschung und Lehre (IFL), Molecular and Experimental Cardiology, Ruhr University Bochum, 44801 Bochum, Germany.
Insights
Inherited cardiomyopathies, often caused by sarcomeric protein gene defects, impair heart function. Understanding these genetic alterations is key to developing new therapies and improving patient prognostication.
Area of Science:
- Cardiology
- Genetics
- Molecular Biology
Background:
- Inherited cardiomyopathies are diverse heart muscle disorders affecting cardiac structure and function.
- Sarcomeric protein gene defects are primary drivers of contractile dysfunction and disease progression.
Purpose of the Study:
- To review the functional consequences of inherited cardiomyopathies on myocardial contraction and kinetics.
- To highlight structural and functional alterations in sarcomeric variants contributing to disease pathogenesis.
- To focus on mutation-induced changes in cardiomyocyte mechanics.
Main Methods:
- Literature review of inherited cardiomyopathies.
- Analysis of sarcomeric protein variants and their impact on cardiac function.
- Examination of mutation-induced alterations in cardiomyocyte mechanics.
Main Results:
- Sarcomeric gene defects lead to significant perturbations in myocardial contraction and kinetics.
- Specific sarcomeric variants exhibit distinct structural and functional alterations driving disease.
- Mutations directly impact cardiomyocyte mechanics, contributing to cardiomyopathy development.
Conclusions:
- Understanding the molecular basis of inherited cardiomyopathies is crucial for therapeutic development.
- Novel agents targeting sarcomere contractility are emerging.
- Early genetic defect identification improves patient prognostication and disease prevention.
Abstract:
Inherited cardiomyopathies form a heterogenous group of disorders that affect the structure and function of the heart. Defects in the genes encoding sarcomeric proteins are associated with various perturbations that induce contractile dysfunction and promote disease development. In this review we aimed to outline the functional consequences of the major inherited cardiomyopathies in terms of myocardial contraction and kinetics, and to highlight the structural and functional alterations in some sarcomeric variants that have been demonstrated to be involved in the pathogenesis of the inherited cardiomyopathies. A particular focus was made on mutation-induced alterations in cardiomyocyte mechanics. Since no disease-specific treatments for familial cardiomyopathies exist, several novel agents have been developed to modulate sarcomere contractility. Understanding the molecular basis of the disease opens new avenues for the development of new therapies. Furthermore, the earlier the awareness of the genetic defect, the better the clinical prognostication would be for patients and the better the prevention of development of the disease.
Related Concept Videos
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis I: Introduction

